954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus
Published in: | Journal for ImmunoTherapy of Cancer |
---|---|
Main Authors: | , , , , , , , |
Format: | Conference Object |
Language: | unknown |
Published: |
BMJ Publishing Group Ltd
2021
|
Subjects: | |
Online Access: | http://dx.doi.org/10.1136/jitc-2021-sitc2021.954 https://syndication.highwire.org/content/doi/10.1136/jitc-2021-SITC2021.954 |
Description not available. |